Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RUEL

Showing results (1211-1220 of 1,486) with videos related to

Pageof 149
Sort By:
Cancer|May 13, 2004
Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II TrialPrimo N Lara, Karen Giselle Chee, Jeff Longmate, et al.
The American Journal of Gastroenterology|November 12, 2009
Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis CPhilip Vutien, Nghia H Nguyen, Huy N Trinh, et al.
Current Developments in Nutrition|May 23, 2020
Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral TherapyJulia L Finkelstein, Heather S Herman, Albert Plenty, et al.
Nature Communications|October 27, 2019
Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarctionSarah McLaughlin, Brian McNeill, James Podrebarac, et al.
Oncotarget|October 14, 2015
Deciphering the molecular basis of invasiveness in Sdhb-deficient cellsCéline Loriot, Mélanie Domingues, Adeline Berger, et al.
The Lancet. HIV|July 21, 2022
What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studiesTom G Jacobs, Stef Schouwenburg, Martina Penazzato, et al.
AIDS (London, England)|April 29, 2010
HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan childrenMichael J Boivin, Theodore D Ruel, Hannah E Boal, et al.
Journal of Tissue Engineering and Regenerative Medicine|April 30, 2016
Microstructured human fibroblast-derived extracellular matrix scaffold for vascular media fabricationJean-Michel Bourget, Véronique Laterreur, Robert Gauvin, et al.
Clinical Pharmacology and Therapeutics|February 11, 2017
Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria ChemopreventionR Kajubi, L Huang, P Jagannathan, et al.
Lancet (London, England)|March 27, 2019
Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trialRichard Kajubi, Teddy Ochieng, Abel Kakuru, et al.
Pageof 149

Showing results (1211-1220 of 1,486) with videos related to

Sort By:
Pageof 149
Cancer|May 13, 2004
Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II TrialPrimo N Lara, Karen Giselle Chee, Jeff Longmate, et al.
The American Journal of Gastroenterology|November 12, 2009
Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis CPhilip Vutien, Nghia H Nguyen, Huy N Trinh, et al.
Current Developments in Nutrition|May 23, 2020
Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral TherapyJulia L Finkelstein, Heather S Herman, Albert Plenty, et al.
Nature Communications|October 27, 2019
Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarctionSarah McLaughlin, Brian McNeill, James Podrebarac, et al.
Oncotarget|October 14, 2015
Deciphering the molecular basis of invasiveness in Sdhb-deficient cellsCéline Loriot, Mélanie Domingues, Adeline Berger, et al.
The Lancet. HIV|July 21, 2022
What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studiesTom G Jacobs, Stef Schouwenburg, Martina Penazzato, et al.
AIDS (London, England)|April 29, 2010
HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan childrenMichael J Boivin, Theodore D Ruel, Hannah E Boal, et al.
Journal of Tissue Engineering and Regenerative Medicine|April 30, 2016
Microstructured human fibroblast-derived extracellular matrix scaffold for vascular media fabricationJean-Michel Bourget, Véronique Laterreur, Robert Gauvin, et al.
Clinical Pharmacology and Therapeutics|February 11, 2017
Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria ChemopreventionR Kajubi, L Huang, P Jagannathan, et al.
Lancet (London, England)|March 27, 2019
Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trialRichard Kajubi, Teddy Ochieng, Abel Kakuru, et al.
Pageof 149